{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T09:20:15Z","timestamp":1775294415660,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T00:00:00Z","timestamp":1543881600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Pediatr"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s12098-018-2812-z","type":"journal-article","created":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T01:49:31Z","timestamp":1543888171000},"page":"229-232","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Revised Antituberculosis Drug Doses and Hepatotoxicity in HIV Negative Children"],"prefix":"10.1007","volume":"86","author":[{"given":"C. K.","family":"Indumathi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aruna","family":"Sethuraman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saurav","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Savita","family":"Krishnamurthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,12,4]]},"reference":[{"key":"2812_CR1","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/j.1440-1746.2007.05207.x","volume":"23","author":"A Tostmann","year":"2008","unstructured":"Tostmann A, Boeree MJ, Aarnoutse RE, De Lange W, Van Der Ven AJ, Dekhuijzen R. Antituberculosis drug-induced hepatotoxicity: concise up-to-date review. J Gastroenterol Hepatol. 2008;23:192\u2013202.","journal-title":"J Gastroenterol Hepatol"},{"key":"2812_CR2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4103\/TROG_20113203_167","volume":"32","author":"H Devarbhavi","year":"2011","unstructured":"Devarbhavi H. Antituberculous drug-induced liver injury: current perspective. Trop Gastroenterol. 2011;32:167\u201374.","journal-title":"Trop Gastroenterol"},{"key":"2812_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.4081\/pr.2011.e16","volume":"3","author":"PR Donald","year":"2011","unstructured":"Donald PR. Antituberculosis drug-induced hepatotoxicity in children. Pediatr Rep. 2011;3:51\u201364.","journal-title":"Pediatr Rep"},{"key":"2812_CR4","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1378\/chest.09-2120","volume":"137","author":"\u0130 Devrim","year":"2010","unstructured":"Devrim \u0130, Olukman \u00d6, Can D, Dizdarer C. Risk factors for isoniazid hepatotoxicity in children with latent TB and TB: difference from adults. Chest. 2010;137:737\u20138.","journal-title":"Chest"},{"key":"2812_CR5","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1007\/s12098-017-2570-3","volume":"85","author":"A Kumar","year":"2017","unstructured":"Kumar A, Sood V, Khanna R, et al. Clinical spectrum and outcome of pediatric drug induced liver injury. Indian J Pediatr. 2017;85:676\u20138.","journal-title":"Indian J Pediatr"},{"key":"2812_CR6","unstructured":"World Health Organization. Rapid Advice: Treatment of Tuberculosis in Children. 2010; Available at: www.who.int\/tb\/publications . Accessed 19 July 2018."},{"key":"2812_CR7","doi-asserted-by":"publisher","first-page":"S184","DOI":"10.1086\/651490","volume":"50","author":"S Swaminathan","year":"2010","unstructured":"Swaminathan S, Rekha B. Pediatric tuberculosis: global overview and challenges. Clin Infect Dis. 2010;50:S184\u201394.","journal-title":"Clin Infect Dis"},{"key":"2812_CR8","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12879-015-0862-7","volume":"15","author":"A Mukherjee","year":"2015","unstructured":"Mukherjee A, Velpandian T, Singla M, Kanhiya K, Kabra SK, Lodha R. Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in Indian children. BMC Infect Dis. 2015;15:126.","journal-title":"BMC Infect Dis"},{"key":"2812_CR9","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1067\/mcp.2002.126175","volume":"72","author":"K Ohkawa","year":"2002","unstructured":"Ohkawa K, Hashiguchi M, Ohno K, et al. Risk factors for antituberculous chemotherapy-induced hepatotoxicity in Japanese pediatric patients. Clin Pharmacol Ther. 2002;72:220\u20136.","journal-title":"Clin Pharmacol Ther"},{"key":"2812_CR10","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/S1665-2681(19)31492-9","volume":"11","author":"S Mansukhani","year":"2012","unstructured":"Mansukhani S, Shah I. Hepatic dysfunction in children with tuberculosis on treatment with antituberculous therapy. Ann Hepatol. 2012;11:96\u20139.","journal-title":"Ann Hepatol"},{"key":"2812_CR11","doi-asserted-by":"publisher","first-page":"115","DOI":"10.4314\/ejhs.v27i2.3","volume":"27","author":"G Aishatu","year":"2017","unstructured":"Aishatu G, Rasheedah I, Wahab J, Sheni M, Damilola O, Adeniyi O. Hepatotoxicity due to antituberculosis therapy among paediatric patients seen at the University of Ilorin Teaching Hospital, north Central Nigeria. Ethiop J Health Sci. 2017;27:115\u201320.","journal-title":"Ethiop J Health Sci"},{"key":"2812_CR12","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1164\/rccm.200510-1666ST","volume":"174","author":"JJ Saukkonen","year":"2006","unstructured":"Saukkonen JJ, Cohn DL, Jasmer RM, et al. An official ATS statement: hepatotoxicity of antituberculosis therapy. Am J Respir Crit Care Med. 2006;174:935\u201352.","journal-title":"Am J Respir Crit Care Med"},{"key":"2812_CR13","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1001\/jama.281.11.1014","volume":"281","author":"CM Nolan","year":"1999","unstructured":"Nolan CM, Goldberg SV, Buskin SE. Hepatotoxicity associated with isoniazid preventive therapy: a 7-year survey from a public health tuberculosis clinic. JAMA. 1999;281:1014\u20138.","journal-title":"JAMA"},{"key":"2812_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.pid.2014.01.001","volume":"6","author":"C Indumathi","year":"2014","unstructured":"Indumathi C, Kumar G, Sethuraman A, Iyengar A. Evaluation of efficacy and adherence to INH preventive therapy in children at risk to develop active tuberculosis. Pediatr Infect Dis. 2014;6:21\u20134.","journal-title":"Pediatr Infect Dis"},{"key":"2812_CR15","doi-asserted-by":"publisher","first-page":"5560","DOI":"10.1128\/AAC.05429-11","volume":"55","author":"S Thee","year":"2011","unstructured":"Thee S, Seddon JA, Donald PR, et al. Pharmacokinetics of isoniazid, rifampin, and pyrazinamide in children younger than two years of age with tuberculosis: evidence for implementation of revised World Health Organization recommendations. Antimicrob Agents Chemother. 2011;55:5560\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"2812_CR16","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1086\/598192","volume":"48","author":"H McIlleron","year":"2009","unstructured":"McIlleron H, Willemse M, Werely CJ, et al. Isoniazid plasma concentrations in a cohort of south African children with tuberculosis: implications for international pediatric dosing guidelines. Clin Infect Dis. 2009;48:1547\u201353.","journal-title":"Clin Infect Dis"},{"key":"2812_CR17","first-page":"292","volume":"7","author":"PK Mandal","year":"2013","unstructured":"Mandal PK, Mandal A, Bhattacharyya SK. Comparing the daily versus the intermittent regimens of the anti-tubercular chemotherapy in the initial intensive phase in non-HIV, sputum positive, pulmonary tuberculosis patients. J Clin Diagn Res. 2013;7:292\u20135.","journal-title":"J Clin Diagn Res"}],"container-title":["The Indian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12098-018-2812-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-018-2812-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-018-2812-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T08:40:39Z","timestamp":1775292039000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12098-018-2812-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,4]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["2812"],"URL":"https:\/\/doi.org\/10.1007\/s12098-018-2812-z","relation":{},"ISSN":["0019-5456","0973-7693"],"issn-type":[{"value":"0019-5456","type":"print"},{"value":"0973-7693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,4]]},"assertion":[{"value":"12 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Source of Funding"}}]}}